Flexible Functional Service Provider (FSP) Solutions Tailored to Your Needs.
Accelerate your clinical development with ProPharma's expert-driven, scalable FSP services.
At ProPharma, we don't believe in one-size-fits-all. Our Functional Service Provider (FSP) solutions are built around your goals, your teams, and your timelines — giving you the flexibility to evolve without disruption.
Partner with a team that scales with your needs and exceeds your expectations.
Experienced Talent, Ready to Deploy
Access a global network of highly qualified professionals across clinical, data, regulatory, and quality functions – with the expertise to plug in fast and deliver results.
Relentless Commitment to Quality
Every engagement is grounded in industry-leading quality systems, compliance protocols, and a proactive approach to risk mitigation.
Client-First, Always
We operate as an extension of your team, with transparency, accountability, and a shared focus on your goals – not just deliverables.
Flexible. Scalable. Strategic.
Our FSP model is built for growth, pivoting as your study needs evolve. From niche biotech to global pharma, we adapt to your rhythm.
President, FSP Services
Global Head, FSP Services
FSP Medical Writing Division Head
At ProPharma, we forge strategic partnerships with our clients to collaboratively devise optimal strategies and drive remarkable results and operational excellence. With our cutting-edge FSP...
Scaling resources for clinical trials can be a daunting task, especially when demands fluctuate over time. In this case study, a sponsor faced several challenges related to resource allocation and...
Streamlining Clinical Trial Operations: How the FSP Model Transformed a Mid-Sized Biotech Company's Success. In this case study, we delve into the experience of a mid-sized genetic testing and...
1129 20th St NW, Suite 600
Washington, DC 20036
1-202-833-8077
3000 Temple Dr, Suite 200
Windsor, ON N8W 5J6
1-519-252-9555
US and Canada
107 West Hargett St.
Raleigh, NC 27601
274 Discovery Dr, Suite 100 Bozeman, MT 59718
10 Parkway North, Suite 310
Deerfield, IL 60015
200 N. Lasalle Street, Suite 2450
Chicago, IL 60601
1129 20th St NW, Suite 600
Washington, DC 20036
1-202-833-8077
3000 Temple Dr, Suite 200
Windsor, ON N8W 5J6
1-519-252-9555
UK
John Stow House 18
Bevis Mark
London EC3A 7JB
Olliver, Aske, Richmond
North Yorkshire, DL10 5HX
Europe
Siemensdamm 62
13627 Berlin
Schipholweg 59
2316 ZL Leiden
Medicon Village
223 81 LUND
Fleminggatan 18
SE -112 26 Stockholm
Ulica grada Vukovara 269a, 10000 Zagreb, Croatia
Alipašina 29, 71000 Sarajevo, Bosnia and Herzegovina
Beogradskog Bataljona 4, 11000 Belgrade, Serbia
Nedeljka Čabrinovića 65, 11000 Belgrade, Serbia
Bul. Svetoga Petra Cetinjskog 114/I, 81000 Podgorica, Crna Gora
Ul. Arso Mickov 29, 1060 Skopje, Macedonia
st. Fjodor Dostoevski no. 72 (Industrila zone Karpos area Vlae), Skopje
Saturn Boulevard no. 42/A 3rd floor, Ap. 13, 500164 Brasov, Romania
Shartava Street, # 40, Tbilisi, Georgia
Rruga Xhanfize Keko Nr. 56, Njesia Administrative 12, H 2, Z. 505, Tirana, Albania.
Asia Pacific
Suite 6, Ground Level
452 Johnston Street
Abbotsford, VIC 3067
3rd Block, 7th Floor,
My Home Hub, Madhapur, Patrika Nagar, HITEC City,
Hyderabad, Telangana 500081
16F Link Square Shinjuku
5-27-5 Sendagaya, Shibuya-ku, Tokyo, 151-0051
Japan
7th Floor Office F
Armstrong Corporate Center
HV Dela Costa Ave.
Salcedo Village
Makati City
Room 04N162, 4/F, Annex
No. 138 Huaihai Middle Road
Huangpu District
Shanghai
September 10, 2025
FDA’s new crackdown on deceptive drug advertising reshapes pharma marketing. Discover implications for sponsors, compliance strategies, and patient trust.
September 10, 2025
Discover two distinct paths for creating a global audit strategy in medical device companies, focusing on harmonization and compliance efficiency ahead of FDA's 2026 QMSR changes.
September 9, 2025
FDA will now release Complete Response Letters in real time. Learn what this transparency means for drug developers, investors, and the industry.
July 8, 2025
ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...
January 31, 2025
ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.
October 21, 2024
ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.
